Literature DB >> 6286469

Mitogen-induced changes in glycolytic enzymes of mouse lymphocytes: influence of insulin on cell activation in vitro.

F Diaz-Espada, L Lopez-Alarcon.   

Abstract

Activated mouse spleen lymphocytes have increased amounts of the glycolytic enzymes pyruvate kinase and lactate dehydrogenase. No changes were found in hexokinase and in the gluconeogenic enzyme fructose 1,6-diphosphatase. Concanavalin A-activated T cells give higher activities of those enzymes than lipopolysaccharide-activated B lymphoblasts. Insulin treatment results in a stronger increment of the enzyme activity of mitogen-activated cells. Insulin inhibits the initial proliferation induced by either Con A or LPS, but a 50% increase in antibody-forming cells was found in LPS-treated cultures. Insulin may favour the differentiation of activated cells by increasing the rate of the glycolytic pathway.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286469      PMCID: PMC1555467     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  A procedure for removing red cells and dead cells from lymphoid cell suspensions.

Authors:  W F Davidson; C R Parish
Journal:  J Immunol Methods       Date:  1975-06       Impact factor: 2.303

Review 2.  Molecular basis of insulin action.

Authors:  M P Czech
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

3.  Changes in glycolytic enzyme levels and isozyme expression in human lymphocytes during blast transformation.

Authors:  M V Kester; T L Phillips; R W Gracy
Journal:  Arch Biochem Biophys       Date:  1977-10       Impact factor: 4.013

4.  Development of B cell subsets: effect of priming on in vitro TNP-LPS responsiveness.

Authors:  F Diaz-Espada; C Martinez-Alonso; R R Bernabe
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

5.  Insulin-like activity of concanavalin A and wheat germ agglutinin--direct interactions with insulin receptors.

Authors:  P Cuatrecasas; G P Tell
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

6.  H-2 antigen-specific cytotoxic T cells induced by concanavalin A: estimation of their relative frequency.

Authors:  M J Bevan; R E Langman; M Cohn
Journal:  Eur J Immunol       Date:  1976-03       Impact factor: 5.532

7.  Triggering mechanism of B lymphocytes. I. Effect of anti-immunoglobulin and enhancing soluble factor on differentiation and proliferation of B cells.

Authors:  T Kishimoto; T Miyake; Y Nishizawa; T Watanabe; Y Yamamura
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

8.  Emergence of insulin receptors on human lymphocytes during in vitro transformation.

Authors:  U Krug; F Krug; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

9.  Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. IV. Special subregion assignment of the gene(s) that codes for the suppressive T-cell factor in the H-2 histocompatibility complex.

Authors:  T Tada; M Taniguchi; C S David
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

10.  Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses.

Authors:  A Coutinho; E Gronowicz; W W Bullock; G Möller
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

View more
  3 in total

1.  Endocrine regulation of the immune system.

Authors:  W Kiess; B H Belohradsky
Journal:  Klin Wochenschr       Date:  1986-01-02

Review 2.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

Review 3.  Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield.

Authors:  K Brand
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.